The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

The Emmy nominee also created Sherri Shepherd's sitcom and worked on 'Ellen,' 'The PJs,' 'Boardwalk Empire' and more.

BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...

Supporters are gearing up for two charity football games across Bristol in aid of the Cystic Fibrosis Comfort Fund. The first ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase ...

Merck said the deal is valued at $107 per ADS, a 23% premium to Verona’s closing price yesterday.

The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).

The prevalence of food allergy is significantly lower in children with cystic fibrosis than in those without the condition in ...

Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.